Inflammasome and Cognitive Symptoms in Human Diseases: Biological Evidence from Experimental Research
Overview
Chemistry
Molecular Biology
Affiliations
Cognitive symptoms are prevalent in the elderly and are associated with an elevated risk of developing dementia. Disease-driven changes can cause cognitive disabilities in memory, attention, and language. The inflammasome is an innate immune intracellular complex that has a critical role in the host defense system, in that it senses infectious pathogen-associated and endogenous danger-associated molecular patterns. An unbalanced or dysregulated inflammasome is associated with infectious, inflammatory, and neurodegenerative diseases. Due to its importance in such pathological conditions, the inflammasome is an emerging drug target for human diseases. A growing number of studies have revealed links between cognitive symptoms and the inflammasome. Several studies have shown that reducing the inflammasome component mitigates cognitive symptoms in diseased states. Therefore, understanding the inflammasome regulatory mechanisms may be required for the prevention and treatment of cognitive symptoms. The purpose of this review is to discuss the current understanding of the inflammasome and its relationships with cognitive symptoms in various human diseases.
Mellado S, Morillo-Bargues M, Perpina-Clerigues C, Garcia-Garcia F, Moreno-Manzano V, Guerri C Neural Regen Res. 2024; 20(4):1153-1163.
PMID: 38989953 PMC: 11438346. DOI: 10.4103/NRR.NRR-D-23-01397.
Oh my gut! Is the microbial origin of neurodegenerative diseases real?.
Walker A, Czyz D Infect Immun. 2023; 91(10):e0043722.
PMID: 37750713 PMC: 10580905. DOI: 10.1128/iai.00437-22.
Inflammation and cognition in severe mental illness: patterns of covariation and subgroups.
Saether L, Ueland T, Haatveit B, Maglanoc L, Szabo A, Djurovic S Mol Psychiatry. 2022; 28(3):1284-1292.
PMID: 36577840 PMC: 10005942. DOI: 10.1038/s41380-022-01924-w.
Hoyt J, Teja N, Jiang T, Rozema L, Gui J, Watts B J Dual Diagn. 2022; 18(4):185-198.
PMID: 36151743 PMC: 9719291. DOI: 10.1080/15504263.2022.2123119.
Nanotargeting of Drug(s) for Delaying Dementia: Relevance of Covid-19 Impact on Dementia.
DArrigo J Am J Alzheimers Dis Other Demen. 2020; 35:1533317520976761.
PMID: 33307726 PMC: 10623919. DOI: 10.1177/1533317520976761.